332 related articles for article (PubMed ID: 30948420)
21. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
[TBL] [Abstract][Full Text] [Related]
22. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
23. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism.
Mishra VK; Subramaniam M; Kari V; Pitel KS; Baumgart SJ; Naylor RM; Nagarajan S; Wegwitz F; Ellenrieder V; Hawse JR; Johnsen SA
Cancer Res; 2017 May; 77(9):2387-2400. PubMed ID: 28249899
[TBL] [Abstract][Full Text] [Related]
26. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
[TBL] [Abstract][Full Text] [Related]
27. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
Lian H; Cheng Y; Wu X
Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
[TBL] [Abstract][Full Text] [Related]
28. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
[TBL] [Abstract][Full Text] [Related]
29. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
30. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
31. Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.
Parakati R; DiMario JX
J Biol Chem; 2013 May; 288(19):13876-84. PubMed ID: 23569208
[TBL] [Abstract][Full Text] [Related]
32. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.
Cao A; Li J; Asadi M; Basgen JM; Zhu B; Yi Z; Jiang S; Doke T; El Shamy O; Patel N; Cravedi P; Azeloglu EU; Campbell KN; Menon M; Coca S; Zhang W; Wang H; Zen K; Liu Z; Murphy B; He JC; D'Agati VD; Susztak K; Kaufman L
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998601
[TBL] [Abstract][Full Text] [Related]
33. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury.
Li H; Zhang W; Zhong F; Das GC; Xie Y; Li Z; Cai W; Jiang G; Choi J; Sidani M; Hyink DP; Lee K; Klotman PE; He JC
Kidney Int; 2018 Dec; 94(6):1160-1176. PubMed ID: 30366682
[TBL] [Abstract][Full Text] [Related]
35. Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.
Horne SJ; Vasquez JM; Guo Y; Ly V; Piret SE; Leonardo AR; Ling J; Revelo MP; Bogenhagen D; Yang VW; He JC; Mallipattu SK
Diabetes; 2018 Nov; 67(11):2420-2433. PubMed ID: 30115650
[TBL] [Abstract][Full Text] [Related]
36. Decreased KAT5 Expression Impairs DNA Repair and Induces Altered DNA Methylation in Kidney Podocytes.
Hishikawa A; Hayashi K; Abe T; Kaneko M; Yokoi H; Azegami T; Nakamura M; Yoshimoto N; Kanda T; Sakamaki Y; Itoh H
Cell Rep; 2019 Jan; 26(5):1318-1332.e4. PubMed ID: 30699357
[TBL] [Abstract][Full Text] [Related]
37. Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene.
Xiong Y; Svingen PA; Sarmento OO; Smyrk TC; Dave M; Khanna S; Lomberk GA; Urrutia RA; Faubion WA
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R608-20. PubMed ID: 24944246
[TBL] [Abstract][Full Text] [Related]
38. Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells.
Hsu CF; Sui CL; Wu WC; Wang JJ; Yang DH; Chen YC; Yu WC; Chang HS
Int J Biochem Cell Biol; 2011 Apr; 43(4):666-73. PubMed ID: 21262377
[TBL] [Abstract][Full Text] [Related]
39. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
[TBL] [Abstract][Full Text] [Related]
40. KLF10 Mediated Epigenetic Dysregulation of Epithelial CD40/CD154 Promotes Endometriosis.
Delaney AA; Khan Z; Zheng Y; Correa LF; Zanfagnin V; Shenoy CC; Schoolmeester JK; Saadalla AM; El-Nashar S; Famuyide AO; Subramaniam M; Hawse JR; Khazaie K; Daftary GS
Biol Reprod; 2016 Sep; 95(3):62. PubMed ID: 27488034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
